{"title": "Pfizer's vaccine efficacy slightly dips among young children", "author": "Paige Twenter", "url": "https://www.beckershospitalreview.com/pharmacy/pfizer-s-vaccine-efficacy-slightly-dips-among-young-children.html", "hostname": "beckershospitalreview.com", "description": "Pfizer's ongoing phase 3 trial studying its COVID-19 vaccine among children between 6 months and 4 years old continued to prove efficacy but showed it has slipped from about 80 percent to 73.2 percent.", "sitename": "beckershospitalreview.com", "date": "2022-08-23", "cleaned_text": "3 trial studying its COVID-19 vaccine among children between 6 months and 4 years old continued to prove efficacy but showed it has [slipped](https://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-announce-updated-covid-19-vaccine-data) from about 80 percent to 73.2 percent. The updated efficacy rate results from 34 study participants, according to Pfizer. Four infant cases showed a vaccine efficacy rate of 75.8 percent and nine cases among children aged between 2 and 4 found a 71.8 percent efficacy rate. The FDA and CDC [initiated](https://www.beckershospitalreview.com/public-health/fda-authorizes-vaccine-for-youngest-children.html) emergency use authorization for Pfizer's vaccine for the youngest population June 17, and Moderna's vaccine for children 6 months to 5 years old was authorized the same day. Pfizer's data at that time \u2014 before omicron subvariants BA.4 and BA.5 surged \u2014 showed an 80 percent efficacy rate. Moderna [reported](https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-moderna-and-pfizer-biontech-covid-19-vaccines-children) a 50.6 percent efficacy rate for infants 6 to 23 months old and a 36.8 percent efficacy rate for 2- to 5-year-olds. As omicron subvariant BA.5 accounts for a high proportion of national cases, Pfizer is [steaming ahead](https://www.beckershospitalreview.com/pharmacy/pfizer-and-biontech-seek-fda-nod-for-omicron-adapted-booster.html) to gain federal approval of its tweaked "}